Title : Targeted therapy in combination with gemcitabine in non-small cell lung cancer.

Pub. Date : 2003 Aug

PMID : 12917817






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Overexpression of ERCC1 correlates with poor survival in gemcitabine/cisplatin-treated non-small cell lung cancer patients. gemcitabine ERCC excision repair 1, endonuclease non-catalytic subunit Homo sapiens
2 Preliminary findings that a subset of gemcitabine/cisplatin-treated patients with low ERCC1 and RRM1 mRNA levels show a significantly longer survival and highlight the possibilities of individually tailored chemotherapy. gemcitabine ERCC excision repair 1, endonuclease non-catalytic subunit Homo sapiens